Angelor
VC Fund
Lyon, France
Angelor is a VC fund in Lyon focused on Medical Device and Health Care. We support private investors so called business angels by providing them with a professional and confidential services like searching investment opportunities, negotiating deals, investing with the right legal tools, following investments and finding exit opportunities.We can serve both new business angels or experienced ones, private individualswho want to invest directly with entrepreneurs, or group of individuals like family offices who want to share the experience.We are always looking for some good investment opportunities, so if you are an entrepreneur, do not hesitate to send us your executive summary ! It's free, efficent and confidential...
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Angelor invests in
Stages Angelor invests in
Countries Angelor invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.2M–$15M
- Series B
- $1.1M–$15M
- Venture - Series Unknown
- $1.1M–$2.2M
Investment Focus
Industry
- Medical Device 3 (19%)
- Health Care 2 (13%)
- Biotechnology 2 (13%)
- Artificial Intelligence 2 (13%)
- Advice 1 (6%)
Stage
- Seed 4 (25%)
- Venture - Series Unknown 3 (19%)
- Series B 2 (13%)
- Funding Round 2 (13%)
- Pre-Seed 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sebastien Bonte
Founding President
|
Founding President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Brenus Pharma
|
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $12.6M / Series A / Jul 20, 2026 | |
Bobine Chemistry
|
Bobine is developing a chemical plastic recycling technology that enables the production of virgin-grade polymers from non-recyclable plastic waste. By utilizing heterogeneous catalysis and electromagnetic induction, this technology allows for the large-scale production of olefins from waste without the need for steam cracking or hydrotreatment. | $15.3M / Seed / Feb 04, 2026 | |
Dillico
|
Dillico is a deep technology business that is developing new equipment to simplify and improve the production of mRNA vaccines and medicines, with the purpose of increasing global healthcare access. | $8.8M / Seed / Jul 09, 2025 | |
|
Brenus Pharma
|
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $25M / Series A / Sep 18, 2024 | |
Pixee Medical
|
Pixee Medical is a manufacturing company that produces computer-assisted surgery solutions using computer vision and AI technologies. | $15.1M / Series B / Feb 08, 2024 | |
B2eBike
|
B2ebike provides comprehensive electric bicycle fleet (VAE) solutions for businesses and communities. The best strategy to convert to a soft form of transportation. | $1.9M / Venture - Series Unknown / Jan 04, 2024 | |
Inalve
|
Inalve produces fresh microalgae for various fields, such as animal nutrition and health, cosmetics, and nutraceutics. They use a new, resource-efficient industrial process to cultivate microalgae. They also use the sun and water, to which they add mineral ingredients, to promote the growth of microalgae. | $2.2M / Venture - Series Unknown / Dec 11, 2023 | |
MAG4HEALTH
|
MAG4HEALTH is a Developer of magnetoencephalography. Magnetoencephalography (MEG) are brain imaging technologies that display neural activity. | $5.7M / Seed / May 23, 2023 | |
NoWW
|
NoWW is the turnkey deposit for zero packaging waste in food retail. | $1.1M / Venture - Series Unknown / Apr 27, 2023 | |
ABC Transfer
|
ABC Transfer is a biopharmaceutical company that develops Rapid Transfer Systems (RTS) solutions. | $1.1M / Series B / Jun 01, 2022 | |
| See all 16 investments → | |||
Co-Investors
Bpifrance
6 deals together
UI Investissement
4 deals together
Auvergne-Rhône-Alpes Regional Future Industry Fund
2 deals together
Investsud
2 deals together
KREAXI
2 deals together
33 California
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Angelor invest in?
Angelor invests primarily in Medical Device, Health Care and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 16 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Angelor's check size?
Angelor typically joins rounds of $1.2M–$15M at Seed, $1.1M–$15M at Series B and $1.1M–$2.2M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Angelor participates in.
How do I contact Angelor?
Public channels for Angelor include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Angelor?
The team at Angelor includes Sebastien Bonte (Founding President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
